APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ertapenem Sodium for Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ertapenem Sodium for Injection Market Analysis and Forecast 2026-2032

Report ID 173989340226 December 2025199 pages

Choose your research edition.

Industry ResearchErtapenem Sodium for Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ertapenem Sodium for Injection Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Ertapenem Sodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ertapenem Sodium for Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ertapenem Sodium for Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Ertapenem Sodium for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ertapenem Sodium for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ertapenem Sodium for Injection include Chongqing Shenghuaxi Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., Qilu Anti Pharmaceutical Co., Ltd., Hainan Herui Pharmaceutical Co., Ltd., Unitech Biotech, Par Pharmaceutical, NorthStar Rx and Intelicure Lifesciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ertapenem Sodium for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ertapenem Sodium for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Ertapenem Sodium for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ertapenem Sodium for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ertapenem Sodium for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ertapenem Sodium for Injection sales, projected growth trends, production technology, application and end-user industry.

Ertapenem Sodium for Injection Segment by Company

Chongqing Shenghuaxi Pharmaceutical Co., Ltd.

Sichuan Pharmaceutical Preparation Co., Ltd.

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

Qilu Anti Pharmaceutical Co., Ltd.

Hainan Herui Pharmaceutical Co., Ltd.

Unitech Biotech

Par Pharmaceutical

NorthStar Rx

Intelicure Lifesciences

EUGIA PHARMA INC

ACS DOBFAR SPA

Ertapenem Sodium for Injection Segment by Type

0.5g

1g

Ertapenem Sodium for Injection Segment by Application

Hospital

Clinic

Other

Ertapenem Sodium for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ertapenem Sodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ertapenem Sodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ertapenem Sodium for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ertapenem Sodium for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ertapenem Sodium for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ertapenem Sodium for Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ertapenem Sodium for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.5g Major Manufacturers Table 3. 1g Major Manufacturers Table 4. Global Ertapenem Sodium for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Ertapenem Sodium for Injection Industry Trends Table 9. Ertapenem Sodium for Injection Industry Drivers Table 10. Ertapenem Sodium for Injection Industry Opportunities and Challenges Table 11. Ertapenem Sodium for Injection Industry Restraints Table 12. Global Ertapenem Sodium for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Ertapenem Sodium for Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Ertapenem Sodium for Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Ertapenem Sodium for Injection Revenue Market Share by Region (2021-2026) Table 16. Global Ertapenem Sodium for Injection Revenue Market Share by Region (2027-2032) Table 17. Global Ertapenem Sodium for Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Ertapenem Sodium for Injection Sales by Region (2021-2026) & (K Units) Table 19. Global Ertapenem Sodium for Injection Sales by Region (2027-2032) & (K Units) Table 20. Global Ertapenem Sodium for Injection Sales Market Share by Region (2021-2026) Table 21. Global Ertapenem Sodium for Injection Sales Market Share by Region (2027-2032) Table 22. Global Ertapenem Sodium for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Ertapenem Sodium for Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Ertapenem Sodium for Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Ertapenem Sodium for Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Ertapenem Sodium for Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Ertapenem Sodium for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Ertapenem Sodium for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Ertapenem Sodium for Injection Manufacturers, Product Type & Application Table 30. Global Ertapenem Sodium for Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Ertapenem Sodium for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Ertapenem Sodium for Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Ertapenem Sodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Ertapenem Sodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2026) Table 37. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2027-2032) Table 38. Global Ertapenem Sodium for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units) Table 40. Global Ertapenem Sodium for Injection Sales by Type (2027-2032) & (K Units) Table 41. Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2026) Table 42. Global Ertapenem Sodium for Injection Sales Market Share by Type (2027-2032) Table 43. Global Ertapenem Sodium for Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Ertapenem Sodium for Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Ertapenem Sodium for Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Ertapenem Sodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Ertapenem Sodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021-2026) Table 49. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2027-2032) Table 50. Global Ertapenem Sodium for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Ertapenem Sodium for Injection Sales by Application (2027-2032) & (K Units) Table 53. Global Ertapenem Sodium for Injection Sales Market Share by Application (2021-2026) Table 54. Global Ertapenem Sodium for Injection Sales Market Share by Application (2027-2032) Table 55. Global Ertapenem Sodium for Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ertapenem Sodium for Injection Price by Application (2027-2032) & (US$/Unit) Table 57. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information Table 58. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Business Overview Table 59. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 61. Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Development Table 62. Sichuan Pharmaceutical Preparation Co., Ltd. Company Information Table 63. Sichuan Pharmaceutical Preparation Co., Ltd. Business Overview Table 64. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 66. Sichuan Pharmaceutical Preparation Co., Ltd. Recent Development Table 67. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information Table 68. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview Table 69. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 71. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Development Table 72. Qilu Anti Pharmaceutical Co., Ltd. Company Information Table 73. Qilu Anti Pharmaceutical Co., Ltd. Business Overview Table 74. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 76. Qilu Anti Pharmaceutical Co., Ltd. Recent Development Table 77. Hainan Herui Pharmaceutical Co., Ltd. Company Information Table 78. Hainan Herui Pharmaceutical Co., Ltd. Business Overview Table 79. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio Table 81. Hainan Herui Pharmaceutical Co., Ltd. Recent Development Table 82. Unitech Biotech Company Information Table 83. Unitech Biotech Business Overview Table 84. Unitech Biotech Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Unitech Biotech Ertapenem Sodium for Injection Product Portfolio Table 86. Unitech Biotech Recent Development Table 87. Par Pharmaceutical Company Information Table 88. Par Pharmaceutical Business Overview Table 89. Par Pharmaceutical Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio Table 91. Par Pharmaceutical Recent Development Table 92. NorthStar Rx Company Information Table 93. NorthStar Rx Business Overview Table 94. NorthStar Rx Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. NorthStar Rx Ertapenem Sodium for Injection Product Portfolio Table 96. NorthStar Rx Recent Development Table 97. Intelicure Lifesciences Company Information Table 98. Intelicure Lifesciences Business Overview Table 99. Intelicure Lifesciences Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio Table 101. Intelicure Lifesciences Recent Development Table 102. EUGIA PHARMA INC Company Information Table 103. EUGIA PHARMA INC Business Overview Table 104. EUGIA PHARMA INC Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio Table 106. EUGIA PHARMA INC Recent Development Table 107. ACS DOBFAR SPA Company Information Table 108. ACS DOBFAR SPA Business Overview Table 109. ACS DOBFAR SPA Ertapenem Sodium for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio Table 111. ACS DOBFAR SPA Recent Development Table 112. North America Ertapenem Sodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Ertapenem Sodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units) Table 115. North America Ertapenem Sodium for Injection Sales by Type (2027-2032) & (K Units) Table 116. North America Ertapenem Sodium for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 117. North America Ertapenem Sodium for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 118. North America Ertapenem Sodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Ertapenem Sodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units) Table 121. North America Ertapenem Sodium for Injection Sales by Application (2027-2032) & (K Units) Table 122. North America Ertapenem Sodium for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 123. North America Ertapenem Sodium for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 124. North America Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Ertapenem Sodium for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Ertapenem Sodium for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 128. North America Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 129. North America Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 130. North America Ertapenem Sodium for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 131. North America Ertapenem Sodium for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 132. United States Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 133. Canada Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 134. Mexico Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 135. Europe Ertapenem Sodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Ertapenem Sodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units) Table 138. Europe Ertapenem Sodium for Injection Sales by Type (2027-2032) & (K Units) Table 139. Europe Ertapenem Sodium for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Europe Ertapenem Sodium for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Europe Ertapenem Sodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Ertapenem Sodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units) Table 144. Europe Ertapenem Sodium for Injection Sales by Application (2027-2032) & (K Units) Table 145. Europe Ertapenem Sodium for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Europe Ertapenem Sodium for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Europe Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Ertapenem Sodium for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Ertapenem Sodium for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. Europe Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 152. Europe Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 153. Europe Ertapenem Sodium for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Europe Ertapenem Sodium for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Germany Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 156. France Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 157. U.K. Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 158. Italy Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 159. Russia Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 160. Spain Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 162. Switzerland Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 163. Sweden Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 164. Poland Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 165. China Ertapenem Sodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 166. China Ertapenem Sodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 167. China Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units) Table 168. China Ertapenem Sodium for Injection Sales by Type (2027-2032) & (K Units) Table 169. China Ertapenem Sodium for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 170. China Ertapenem Sodium for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 171. China Ertapenem Sodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 172. China Ertapenem Sodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 173. China Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units) Table 174. China Ertapenem Sodium for Injection Sales by Application (2027-2032) & (K Units) Table 175. China Ertapenem Sodium for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 176. China Ertapenem Sodium for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Asia Ertapenem Sodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Ertapenem Sodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units) Table 180. Asia Ertapenem Sodium for Injection Sales by Type (2027-2032) & (K Units) Table 181. Asia Ertapenem Sodium for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 182. Asia Ertapenem Sodium for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 183. Asia Ertapenem Sodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Ertapenem Sodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units) Table 186. Asia Ertapenem Sodium for Injection Sales by Application (2027-2032) & (K Units) Table 187. Asia Ertapenem Sodium for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 188. Asia Ertapenem Sodium for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 189. Asia Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Ertapenem Sodium for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Ertapenem Sodium for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. Asia Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 194. Asia Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 195. Asia Ertapenem Sodium for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 196. Asia Ertapenem Sodium for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 197. Japan Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 198. South Korea Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 199. India Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 200. Australia Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 201. Taiwan Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Ertapenem Sodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Ertapenem Sodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Ertapenem Sodium for Injection Sales by Type (2021-2026) & (K Units) Table 206. SAMEA Ertapenem Sodium for Injection Sales by Type (2027-2032) & (K Units) Table 207. SAMEA Ertapenem Sodium for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 208. SAMEA Ertapenem Sodium for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 209. SAMEA Ertapenem Sodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Ertapenem Sodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Ertapenem Sodium for Injection Sales by Application (2021-2026) & (K Units) Table 212. SAMEA Ertapenem Sodium for Injection Sales by Application (2027-2032) & (K Units) Table 213. SAMEA Ertapenem Sodium for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 214. SAMEA Ertapenem Sodium for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 215. SAMEA Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Ertapenem Sodium for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Ertapenem Sodium for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 219. SAMEA Ertapenem Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 220. SAMEA Ertapenem Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 221. SAMEA Ertapenem Sodium for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 222. SAMEA Ertapenem Sodium for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 223. Brazil Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 224. Argentina Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 225. Chile Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 226. Colombia Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 227. Peru Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 229. Israel Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 230. UAE Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 231. Turkey Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 232. Iran Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 233. Egypt Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Ertapenem Sodium for Injection Distributors List Table 237. Ertapenem Sodium for Injection Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Ertapenem Sodium for Injection Image Figure 2. Global Ertapenem Sodium for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ertapenem Sodium for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.5g Image Figure 5. 1g Image Figure 6. Global Ertapenem Sodium for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ertapenem Sodium for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Ertapenem Sodium for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Ertapenem Sodium for Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Ertapenem Sodium for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Ertapenem Sodium for Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Ertapenem Sodium for Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Ertapenem Sodium for Injection Sales (2021-2032) & (K Units) Figure 17. Global Ertapenem Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Ertapenem Sodium for Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Ertapenem Sodium for Injection Sales YoY (2021-2032) & (K Units) Figure 20. Europe Ertapenem Sodium for Injection Sales YoY (2021-2032) & (K Units) Figure 21. China Ertapenem Sodium for Injection Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Ertapenem Sodium for Injection Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Ertapenem Sodium for Injection Sales YoY (2021-2032) & (K Units) Figure 24. Global Ertapenem Sodium for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Ertapenem Sodium for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Ertapenem Sodium for Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Ertapenem Sodium for Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Ertapenem Sodium for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Ertapenem Sodium for Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2032) Figure 33. Global Ertapenem Sodium for Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Ertapenem Sodium for Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Ertapenem Sodium for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Ertapenem Sodium for Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Ertapenem Sodium for Injection Sales Market Share by Application (2021-2032) Figure 39. North America Ertapenem Sodium for Injection Revenue Share by Type (2021-2032) Figure 40. North America Ertapenem Sodium for Injection Sales Share by Type (2021-2032) Figure 41. North America Ertapenem Sodium for Injection Revenue Share by Application (2021-2032) Figure 42. North America Ertapenem Sodium for Injection Sales Share by Application (2021-2032) Figure 43. North America Ertapenem Sodium for Injection Revenue Share by Country (2021-2032) Figure 44. North America Ertapenem Sodium for Injection Sales Share by Country (2021-2032) Figure 45. Europe Ertapenem Sodium for Injection Revenue Share by Type (2021-2032) Figure 46. Europe Ertapenem Sodium for Injection Sales Share by Type (2021-2032) Figure 47. Europe Ertapenem Sodium for Injection Revenue Share by Application (2021-2032) Figure 48. Europe Ertapenem Sodium for Injection Sales Share by Application (2021-2032) Figure 49. Europe Ertapenem Sodium for Injection Revenue Share by Country (2021-2032) Figure 50. Europe Ertapenem Sodium for Injection Sales Share by Country (2021-2032) Figure 51. China Ertapenem Sodium for Injection Revenue Share by Type (2021-2032) Figure 52. China Ertapenem Sodium for Injection Sales Share by Type (2021-2032) Figure 53. China Ertapenem Sodium for Injection Revenue Share by Application (2021-2032) Figure 54. China Ertapenem Sodium for Injection Sales Share by Application (2021-2032) Figure 55. Asia Ertapenem Sodium for Injection Revenue Share by Type (2021-2032) Figure 56. Asia Ertapenem Sodium for Injection Sales Share by Type (2021-2032) Figure 57. Asia Ertapenem Sodium for Injection Revenue Share by Application (2021-2032) Figure 58. Asia Ertapenem Sodium for Injection Sales Share by Application (2021-2032) Figure 59. Asia Ertapenem Sodium for Injection Revenue Share by Country (2021-2032) Figure 60. Asia Ertapenem Sodium for Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Ertapenem Sodium for Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Ertapenem Sodium for Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Ertapenem Sodium for Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Ertapenem Sodium for Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Ertapenem Sodium for Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Ertapenem Sodium for Injection Sales Share by Country (2021-2032) Figure 67. Ertapenem Sodium for Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Ertapenem Sodium for Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5g
  • 1g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
  • Sichuan Pharmaceutical Preparation Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  • Qilu Anti Pharmaceutical Co., Ltd.
  • Hainan Herui Pharmaceutical Co., Ltd.
  • Unitech Biotech
  • Par Pharmaceutical
  • NorthStar Rx
  • Intelicure Lifesciences
  • EUGIA PHARMA INC
  • ACS DOBFAR SPA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ertapenem Sodium for Injection Market by Type
  3. 1.2.1 Global Ertapenem Sodium for Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.5g
  5. 1.2.3 1g
  6. 1.3 Ertapenem Sodium for Injection Market by Application
  7. 1.3.1 Global Ertapenem Sodium for Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Ertapenem Sodium for Injection Market Dynamics
  1. 2.1 Ertapenem Sodium for Injection Industry Trends
  2. 2.2 Ertapenem Sodium for Injection Industry Drivers
  3. 2.3 Ertapenem Sodium for Injection Industry Opportunities and Challenges
  4. 2.4 Ertapenem Sodium for Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ertapenem Sodium for Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ertapenem Sodium for Injection Revenue by Region
  3. 3.2.1 Global Ertapenem Sodium for Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ertapenem Sodium for Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Ertapenem Sodium for Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Ertapenem Sodium for Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ertapenem Sodium for Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ertapenem Sodium for Injection Sales by Region
  9. 3.4.1 Global Ertapenem Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ertapenem Sodium for Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Ertapenem Sodium for Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Ertapenem Sodium for Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ertapenem Sodium for Injection Revenue by Manufacturers
  2. 4.1.1 Global Ertapenem Sodium for Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ertapenem Sodium for Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ertapenem Sodium for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ertapenem Sodium for Injection Sales by Manufacturers
  6. 4.2.1 Global Ertapenem Sodium for Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ertapenem Sodium for Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ertapenem Sodium for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ertapenem Sodium for Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ertapenem Sodium for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ertapenem Sodium for Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ertapenem Sodium for Injection Manufacturers, Product Type & Application
  13. 4.7 Global Ertapenem Sodium for Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ertapenem Sodium for Injection Market CR5 and HHI
  16. 4.8.2 2025 Ertapenem Sodium for Injection Tier 1, Tier 2, and Tier 3
5 Ertapenem Sodium for Injection Market by Type
  1. 5.1 Global Ertapenem Sodium for Injection Revenue by Type
  2. 5.1.1 Global Ertapenem Sodium for Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ertapenem Sodium for Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ertapenem Sodium for Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ertapenem Sodium for Injection Sales by Type
  6. 5.2.1 Global Ertapenem Sodium for Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ertapenem Sodium for Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Ertapenem Sodium for Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ertapenem Sodium for Injection Price by Type
6 Ertapenem Sodium for Injection Market by Application
  1. 6.1 Global Ertapenem Sodium for Injection Revenue by Application
  2. 6.1.1 Global Ertapenem Sodium for Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ertapenem Sodium for Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ertapenem Sodium for Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ertapenem Sodium for Injection Sales by Application
  6. 6.2.1 Global Ertapenem Sodium for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ertapenem Sodium for Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Ertapenem Sodium for Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ertapenem Sodium for Injection Price by Application
7 Company Profiles
  1. 7.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd.
  2. 7.1.1 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  6. 7.1.5 Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Sichuan Pharmaceutical Preparation Co., Ltd.
  8. 7.2.1 Sichuan Pharmaceutical Preparation Co., Ltd. Company Information
  9. 7.2.2 Sichuan Pharmaceutical Preparation Co., Ltd. Business Overview
  10. 7.2.3 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sichuan Pharmaceutical Preparation Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  12. 7.2.5 Sichuan Pharmaceutical Preparation Co., Ltd. Recent Developments
  13. 7.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  14. 7.3.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  18. 7.3.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Qilu Anti Pharmaceutical Co., Ltd.
  20. 7.4.1 Qilu Anti Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Qilu Anti Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Qilu Anti Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  24. 7.4.5 Qilu Anti Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Hainan Herui Pharmaceutical Co., Ltd.
  26. 7.5.1 Hainan Herui Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Hainan Herui Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hainan Herui Pharmaceutical Co., Ltd. Ertapenem Sodium for Injection Product Portfolio
  30. 7.5.5 Hainan Herui Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Unitech Biotech
  32. 7.6.1 Unitech Biotech Company Information
  33. 7.6.2 Unitech Biotech Business Overview
  34. 7.6.3 Unitech Biotech Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Unitech Biotech Ertapenem Sodium for Injection Product Portfolio
  36. 7.6.5 Unitech Biotech Recent Developments
  37. 7.7 Par Pharmaceutical
  38. 7.7.1 Par Pharmaceutical Company Information
  39. 7.7.2 Par Pharmaceutical Business Overview
  40. 7.7.3 Par Pharmaceutical Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Par Pharmaceutical Ertapenem Sodium for Injection Product Portfolio
  42. 7.7.5 Par Pharmaceutical Recent Developments
  43. 7.8 NorthStar Rx
  44. 7.8.1 NorthStar Rx Company Information
  45. 7.8.2 NorthStar Rx Business Overview
  46. 7.8.3 NorthStar Rx Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 NorthStar Rx Ertapenem Sodium for Injection Product Portfolio
  48. 7.8.5 NorthStar Rx Recent Developments
  49. 7.9 Intelicure Lifesciences
  50. 7.9.1 Intelicure Lifesciences Company Information
  51. 7.9.2 Intelicure Lifesciences Business Overview
  52. 7.9.3 Intelicure Lifesciences Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Intelicure Lifesciences Ertapenem Sodium for Injection Product Portfolio
  54. 7.9.5 Intelicure Lifesciences Recent Developments
  55. 7.10 EUGIA PHARMA INC
  56. 7.10.1 EUGIA PHARMA INC Company Information
  57. 7.10.2 EUGIA PHARMA INC Business Overview
  58. 7.10.3 EUGIA PHARMA INC Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 EUGIA PHARMA INC Ertapenem Sodium for Injection Product Portfolio
  60. 7.10.5 EUGIA PHARMA INC Recent Developments
  61. 7.11 ACS DOBFAR SPA
  62. 7.11.1 ACS DOBFAR SPA Company Information
  63. 7.11.2 ACS DOBFAR SPA Business Overview
  64. 7.11.3 ACS DOBFAR SPA Ertapenem Sodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 ACS DOBFAR SPA Ertapenem Sodium for Injection Product Portfolio
  66. 7.11.5 ACS DOBFAR SPA Recent Developments
8 North America
  1. 8.1 North America Ertapenem Sodium for Injection Market Size by Type
  2. 8.1.1 North America Ertapenem Sodium for Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Ertapenem Sodium for Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Ertapenem Sodium for Injection Price by Type (2021-2032)
  5. 8.2 North America Ertapenem Sodium for Injection Market Size by Application
  6. 8.2.1 North America Ertapenem Sodium for Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Ertapenem Sodium for Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Ertapenem Sodium for Injection Price by Application (2021-2032)
  9. 8.3 North America Ertapenem Sodium for Injection Market Size by Country
  10. 8.3.1 North America Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ertapenem Sodium for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ertapenem Sodium for Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ertapenem Sodium for Injection Market Size by Type
  2. 9.1.1 Europe Ertapenem Sodium for Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ertapenem Sodium for Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Ertapenem Sodium for Injection Price by Type (2021-2032)
  5. 9.2 Europe Ertapenem Sodium for Injection Market Size by Application
  6. 9.2.1 Europe Ertapenem Sodium for Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ertapenem Sodium for Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Ertapenem Sodium for Injection Price by Application (2021-2032)
  9. 9.3 Europe Ertapenem Sodium for Injection Market Size by Country
  10. 9.3.1 Europe Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ertapenem Sodium for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ertapenem Sodium for Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ertapenem Sodium for Injection Market Size by Type
  2. 10.1.1 China Ertapenem Sodium for Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Ertapenem Sodium for Injection Sales by Type (2021-2032)
  4. 10.1.3 China Ertapenem Sodium for Injection Price by Type (2021-2032)
  5. 10.2 China Ertapenem Sodium for Injection Market Size by Application
  6. 10.2.1 China Ertapenem Sodium for Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Ertapenem Sodium for Injection Sales by Application (2021-2032)
  8. 10.2.3 China Ertapenem Sodium for Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ertapenem Sodium for Injection Market Size by Type
  2. 11.1.1 Asia Ertapenem Sodium for Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ertapenem Sodium for Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Ertapenem Sodium for Injection Price by Type (2021-2032)
  5. 11.2 Asia Ertapenem Sodium for Injection Market Size by Application
  6. 11.2.1 Asia Ertapenem Sodium for Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ertapenem Sodium for Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Ertapenem Sodium for Injection Price by Application (2021-2032)
  9. 11.3 Asia Ertapenem Sodium for Injection Market Size by Country
  10. 11.3.1 Asia Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ertapenem Sodium for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ertapenem Sodium for Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ertapenem Sodium for Injection Market Size by Type
  2. 12.1.1 SAMEA Ertapenem Sodium for Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ertapenem Sodium for Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ertapenem Sodium for Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Ertapenem Sodium for Injection Market Size by Application
  6. 12.2.1 SAMEA Ertapenem Sodium for Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ertapenem Sodium for Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ertapenem Sodium for Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Ertapenem Sodium for Injection Market Size by Country
  10. 12.3.1 SAMEA Ertapenem Sodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ertapenem Sodium for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ertapenem Sodium for Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ertapenem Sodium for Injection Value Chain Analysis
  2. 13.1.1 Ertapenem Sodium for Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ertapenem Sodium for Injection Production Mode & Process
  6. 13.2 Ertapenem Sodium for Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ertapenem Sodium for Injection Distributors
  9. 13.2.3 Ertapenem Sodium for Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst